GSK
719 hedge funds and large institutions have $9.69B invested in GSK in 2015 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 289 increasing their positions, 233 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 740 → 719 (-21)
17% less capital invested
Capital invested by funds: $11.7B → $9.69B (-$1.97B)
19% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 64
Holders
719
Holding in Top 10
11
Calls
$221M
Puts
$218M
Top Buyers
| 1 | +$303M | |
| 2 | +$75M | |
| 3 | +$54.4M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$41.8M |
| 5 |
Jane Street
New York
|
+$34.6M |
Top Sellers
| 1 | -$456M | |
| 2 | -$357M | |
| 3 | -$172M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$107M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$97.2M |